Svai S. Sanford

Chief Financial Officer, Vivus.

Companies

Rani Therapeutics Holdings, Inc.Chief financial officer Jul 29, 2021 to Jul 8, 2026¹
VivusChief financial officer Nov 8, 2013 to Aug 5, 2015²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Rani Therapeutics Holdings, Inc. RANI258,597 shares³$169.4K at $0.66Mar 27, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Mar 27, 2023Granted 139,000 shares of Rani Therapeutics Holdings, Inc.³
Mar 22, 2023Shares withheld for tax 3,355 shares at $5.95 of Rani Therapeutics Holdings, Inc.⁴
Sep 9, 2022Shares withheld for tax 18,362 shares at $9.89 of Rani Therapeutics Holdings, Inc.⁵
Mar 22, 2022Granted 32,900 shares of Rani Therapeutics Holdings, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARRani Therapeutics Holdings, Inc., Chief financial officer
2
SEC EDGARVivus, Chief financial officer
3
SEC EDGARRani Therapeutics Holdings, Inc. shares after the filing of Mar 27, 2023
4
SEC EDGARForm 4 filed Mar 24, 2023
5
SEC EDGARForm 4 filed Sep 13, 2022
6
SEC EDGARForm 4 filed Mar 24, 2022